Showing results (1051-1060 of 5,010) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|July 28, 2015
Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplantBrian P Mulherin, Mary J Brames, Lawrence H EinhornAmerican Journal of Clinical Oncology|July 28, 2015
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastasesLuciana Caravatta, Francesco Deodato, Marica Ferro, et al.American Journal of Clinical Oncology|August 14, 2015
Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER AnalysisWalid L Shaib, Michael Goodman, Zhengjia Chen, et al.American Journal of Clinical Oncology|January 1, 1988
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogueJ Waxman, G Williams, J Sandow, et al.American Journal of Clinical Oncology|May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal CancerEmerson Y Chen, Charles D Blanke, Daniel G Haller, et al.American Journal of Clinical Oncology|May 22, 2018
The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional ExperienceDustin B Manders, Travis T Sims, April Bailey, et al.American Journal of Clinical Oncology|May 22, 2018
Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer-specific MortalityRenee L Arlow, Lisa E Paddock, Xiaoling Niu, et al.American Journal of Clinical Oncology|May 22, 2018
Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer PatientsDavid A Becker, Charles A Leath, Christen L Walters-Haygood, et al.American Journal of Clinical Oncology|January 1, 1988
Long-term results of treating advanced prostatic cancer with the LH-RH analogue ZoladexC J BeacockAmerican Journal of Clinical Oncology|January 1, 1988
Zoladex treatment of symptomatic prostatic carcinomaI M Holdaway, H K Ibbertson, M S Croxson, et al.Pageof 501